Reported Sep 11, 2024 · Ongoing
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008,…
ProRx LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: ProRx LLC · 619 Jeffers Cir · Exton, PA · 19341-2540
Is this the product you have?
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL2mL Multidose SC Injection vialsCompounded Rx ProductProRx 267-565-7008NDC 84139-210-01
- Lot codes and dates
Lot # ProRx040924-1BUD 10/08/2024
- Amount recalled
- 37 vials
This recall covers 7 products
The agency filed one notice per product. You are reading one of them; the other 6 are below.
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new ProRx LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.